Altered expression of cyclin D1, which is observed in many breast tumors [2], had little effect on most SME transcript levels and cyclin D1 was not associated with the Jun/cdk promoter complexes in oligonucleotide “pull-down” experiments. Here, JUN is linked to breast neoplasm.